Safety Conclusions: 5 Day Treatment
Most common adverse events were headache and GI symptoms
No clinically significant effects on laboratory safety parameters
Increased menstrual disorders in OC users;
3.5% with pleconaril treatment dose
No evidence of increased incidence of pregnancy in women taking pleconaril
Safety profile supports empiric treatment of colds